Skip to content

VHCP Management III, LLC

Follow

13F filer, CIK 1738053, New York, NY

VHCP Management III, LLC reported $132,350,000 across 13 holdings for the quarter ended 2018-09-30, in a 13F-HR filed 2018-11-13. Its ten largest share positions make up 98.61% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-18-011333

Period
2018-09-30
Reported value
$132M
Holdings
13
Top 10 weight
98.61%
New
Sold out

Stakes and trades reported after 2018-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • OKUR ONKURE THERAPEUTICS INC: 13G 2,309,559 shares, 5.7% of the class, 13G filed 2026-11-20, 0001231919-26-001621Timeline
    Accepted , ingested
  • ENTX ENTERA BIO LTD: 13G 8,861,763 shares, 5.1% of the class, 13G filed 2026-10-30, 0001738048-26-000079Timeline
    Accepted , ingested
  • LYCA LYCIA THERAPEUTICS INC: 13G 6,850,237 shares, 11.9% of the class, 13G filed 2026-10-30, 0001738048-26-000077Timeline
    Accepted , ingested
  • FLSC FRAZIER LIFE SCIENCES ACQ-A: 13G 700,000 shares, 9% of the class, 13G filed 2026-10-27, 0001738048-26-000075Timeline
    Accepted , ingested
  • XFOR X4 PHARMACEUTICALS INC: 13G/A 7,644,072 shares, 7.6% of the class, 13G/A filed 2026-11-16, 0001738048-26-000100Timeline
    Accepted , ingested
  • VOR VOR BIOPHARMA INC: 13G/A 6,443,619 shares, 9.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000098Timeline
    Accepted , ingested
  • KRRO KORRO BIO INC: 13G/A 1,474,162 shares, 9.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000096Timeline
    Accepted , ingested
  • JBIO JADE BIOSCIENCES INC: 13G/A 3,858,984 shares, 5.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000094Timeline
    Accepted , ingested
  • HELP HELUS PHARMA INC: 13G/A 2,688,175 shares, 3.5% of the class, 13G/A filed 2026-11-16, 0001738048-26-000092Timeline
    Accepted , ingested
  • CBIO CRESCENT BIOPHARMA INC.: 13G/A 2,228,641 shares, 5.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000090Timeline
    Accepted , ingested
  • ACHV ACHIEVE LIFE SCIENCE INC: 13G/A 5,502,064 shares, 5.2% of the class, 13G/A filed 2026-11-16, 0001738048-26-000088Timeline
    Accepted , ingested

Holdings, Q3 2018

Share positions as resolved from 13F-HR 0000950123-18-011333, largest first. % of portfolio is the value over $132,350,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 1,284,931 shares 1,284,931$28.4M21.47%Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 3,061,091 shares 3,061,091$23.4M17.65%Timeline
ObsEva SAObsEva SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 1,159,789 shares 1,159,789$20.9M15.8%
TRICIDA INCTRICIDA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 650,585 shares 650,585$19.9M15.02%
ENDOCYTE INCENDOCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 600,000 shares 600,000$10.7M8.05%
KINIKSA PHARMACEUTICALS LTDKINIKSA PHARMACEUTICALS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 327,777 shares 327,777$8.36M6.32%
KADMON HOLDINGS INCKADMON HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 2,388,572 shares 2,388,572$7.98M6.03%
MARINUS PHARMACEUTICALS INCMARINUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 672,271 shares 672,271$6.72M5.08%
BELLEROPHON THERAPEUTICS INCBELLEROPHON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 2,274,370 shares 2,274,370$2.46M1.86%
GEMPHIRE THERAPEUTICS INCGEMPHIRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 869,538 shares 869,538$1.79M1.35%
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 50,290 shares 50,290$894K0.68%Timeline
CHEMOCENTRYX INCCHEMOCENTRYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 39,036 shares 39,036$493K0.37%
CONSTELLATION PHARMACEUTICALCONSTELLATION PHARMACEUTICALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 66,667 shares 66,667$449K0.34%

How Q3 2018 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-18-011333 base2018-11-13acceptance time not in the bulk data set